Skip to main content

Table 4 Two-year risk of adverse cardiovascular outcomes after coronary angiography in elective non-diabetes patients with chronic coronary syndrome

From: Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016

 

Patients

Events

Two-year cumulative incidence proportion (95% CI)

Unadjusted IRR (95% CI)

Adjusted IRR* (95% CI)

MACE

   

2004–2006

4847

302

6.3% (5.6–7.0)

Reference

Reference

2007–2009

6104

312

5.2% (4.6–5.7)

0.81 (0.69–0.96)

0.81 (0.69–0.95)

2010–2012

5547

243

4.2% (3.9–5.0)

0.69 (0.59–0.82)

0.65 (0.55–0.78)

2013–2016

7042

272

3.9% (3.5–4.4)

0.61 (0.52–0.72)

0.57 (0.48–0.68)

Myocardial infarction

   

2004–2006

4847

154

3.2% (2.8–3.8)

Reference

Reference

2007–2009

6104

173

2.9% (2.5–3.3)

0.89 (0.71–1.10)

0.89 (0.72–1.11)

2010–2012

5547

125

2.3% (1.0–2.7)

0.70 (0.55–0.89)

0.68 (0.54–0.87)

2013–2016

7042

175

2.5% (2.2–2.9)

0.77 (0.62–0.96)

0.75 (0.60–0.93)

Ischemic stroke

     

2004–2006

4847

72

1.5% (1.2–1.9)

Reference

Reference

2007–2009

6104

69

1.2% (0.9–1.5)

0.76 (0.54–1.05)

0.71 (0.51–0.99)

2010–2012

5547

64

1.2% (0.9–1.5)

0.77 (0.55–1.07)

0.65 (0.46–0.92)

2013–2016

7042

62

0.9% (0.7–1.1)

0.58 (0.42–0.82)

0.48 (0.34–0.68)

Cardiac death

     

2004–2006

4847

102

2.1% (1.8–2.6)

Reference

Reference

2007–2009

6104

99

1.6% (1.4–2.0)

0.77 (0.58–1.01)

0.77 (0.58–1.87)

2010–2012

5547

65

1.2% (0.9–1.5)

0.55 (0.40–0.76)

0.52 (0.38–0.71)

2013–2016

7042

50

0.7% (0.5–0.9)

0.33 (0.24–0.47)

0.31 (0.22–0.44)

Death

2004–2006

4847

229

4.7% (4.2–5.4)

Reference

Reference

2007–2009

6104

270

4.4% (3.9–5.0)

0.93 (0.78–1.11)

0.95 (0.79–1.13)

2010–2012

5547

219

4.0% (3.5–4.5)

0.83 (0.69–1.00)

0.80 (0.66–0.97)

2013–2016

7042

216

3.1% (2.7–3.5)

0.64 (0.53–0.77)

0.61 (0.51–0.74)

  1. *Adjusted for sex, age, smoking, hypertension, previous ischemic stroke, peripheral artery disease, statin treatment, antiplatelet treatment, and oral anti-coagulant treatment. Ischemic stroke and death were additionally adjusted for atrial fibrillation and heart failure